Y. Nagatsu

Biomimetic oxidation of 2-methylimidazole derivative with a chemical model system for cytochrome P-450.

H. Miyachi, Y. Nagatsu, 2002, Chemical & pharmaceutical bulletin.

Oxidative decarboxylation of carboxylic acids by iron porphyrin - iodosylbenzene system

M. Hirobe, T. Higuchi, M. Komuro, 1992 .

Modification of macrophage functions by Shosaikoto (kampo medicine) leads to enhancement of immune response.

M. Inoue, Y. Ogihara, Y. Nagatsu, 1989, Chemical & pharmaceutical bulletin.

Synthesis of carbon‐14 and deuterium labeled 3‐isobutyryl‐2‐isopro‐pylpyrazolo [1, 5‐a]pyridine

Y. Nagatsu, K. Takagi, 1985 .

Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.

K. Kikuchi, S. Ohta, T. Mashino, 1991, Drug metabolism and disposition: the biological fate of chemicals.

[Studies on drug metabolism by use of isotopes. XVIII. Ion cluster technique for detection of urinary metabolites of 1-butyryl-4-cinnamylpiperazine (author's transl)].

S. Baba, Y. Nagatsu, S. Morisita, 1976, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Response of liver to glucocorticoid is altered by administration of shosaikoto (kampo medicine).

M. Inoue, Y. Ogihara, Y. Kikuta, 1990, Chemical and pharmaceutical bulletin.

Anti-hyperlipidemic and anti-atherosclerotic actions of shosaikoto (kampo medicine).

M. Inoue, M. Aburada, Y. Ogihara, 1996, Biological & pharmaceutical bulletin.